Feasibility and pilot randomised controlled trial of a co-designed home-based personalised reablement strategy program delivered via Voice-Controlled Intelligent Personal Assistants in older adults aged 60-89 years with mild cognitive impairment and/or dementia.

Not Applicable

Active, not recruiting

• Conditions: Dementia; Mild cognitive impairment; Neurological - Dementias; Mental Health - Other mental health disorders

• Registration Number: ACTRN12623000898651
• Lead Sponsor: Dementia Australia Research Foundation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-08-22
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Prospective participants must meet the following criteria including English-speaking, aged 60-89 years, reside anywhere in Australia, have a recent (less than 6 months) clinical diagnosis of early dementia (any type) or MCI by a Cognitive, Dementia and Memory Service (CDAMS) Clinic, Neuropsychologist or General Practitioner; have a home Wi-Fi network and smart devices and have a primary carer with at least 50% close contact during the 12-week period.

Exclusion Criteria

Participants will be ineligible if they report currently being unable to walk across a room unaided; are non-English speaking or have difficulty communicating with study personnel or a VIPA device due to speech or hearing problems; unwilling to be randomised; planning to be away from the VIPA device is greater than 4 weeks during the 12-week intervention period; any disorder of such severity that life expectancy is less than 12 months, or any cognitive or physical impairment or disability that in the opinion of the study investigators would result in the participant having difficulty interacting with Buddy Link or performing personalized reablement program safely. These include
- Progressive neurological disorders including Parkinson’s Disease and multiple sclerosis;
- Schizophrenia, other psychotic disorders, bipolar disorder;
- Severe knee or hip arthritis that would interfere with ability to complete functional tests and the intervention;
- Lung disease requiring regular use of supplemental oxygen
- Renal disease requiring dialysis;
- Hyper- or hypothyroidism;
- Cardiovascular disease (including New York Heart Association (NYHA) Class III or IV congestive heart failure, clinically significant valvular disease, history of cardiac arrest, presence of an implantable cardiac defibrillator, or uncontrolled angina)
- Other disorder of such severity that life expectancy is less than 12 months;
- Stroke, hip or knee replacement, spinal surgery, myocardial infarction or major heart surgery in the past 6 months.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Feasibility as measured by greater than or equal to 70% retention in the study, this will be determined by an audit of the study database.<br>[ Upon conclusion of the study (12 weeks post-intervention commencement)<br>];Feasibility as measured by completion of greater than or equal to 66% of the personalised reablement strategy program by accessing the Buddy Link platform to quantify the regularity with which participants engage in the audio, visual and written strategies delivered via VIPA.[ Upon conclusion of the study (12 weeks post-intervention commencement)];Acceptability as measured by overall positive themes expressed by semi structured interviews. [ At the completion of the study (12 week time-point)]